ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 102 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $569,000 | -8.8% | 12,819 | -19.5% | 0.00% | – |
| Q2 2018 | $624,000 | -90.0% | 15,919 | -81.6% | 0.00% | -100.0% |
| Q1 2018 | $6,250,000 | +9.5% | 86,406 | -0.3% | 0.00% | +50.0% |
| Q4 2017 | $5,707,000 | +25.5% | 86,676 | -4.5% | 0.00% | 0.0% |
| Q3 2017 | $4,548,000 | -9.6% | 90,750 | -16.5% | 0.00% | 0.0% |
| Q2 2017 | $5,029,000 | +28.9% | 108,673 | -1.6% | 0.00% | 0.0% |
| Q1 2017 | $3,901,000 | +674.0% | 110,475 | +174.7% | 0.00% | – |
| Q4 2016 | $504,000 | +40.0% | 40,220 | +54.9% | 0.00% | – |
| Q3 2016 | $360,000 | +40.1% | 25,963 | 0.0% | 0.00% | – |
| Q2 2016 | $257,000 | -41.5% | 25,963 | 0.0% | 0.00% | – |
| Q1 2016 | $439,000 | – | 25,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |